Goldman Sachs Maintains Neutral on Organon, Raises Price Target to $20
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst Chris Shibutani has maintained a Neutral rating on Organon (NYSE:OGN) and increased the price target from $18 to $20.
May 03, 2024 | 3:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Goldman Sachs maintains a Neutral rating on Organon, raising the price target from $18 to $20.
The increase in price target by Goldman Sachs suggests a positive outlook on Organon's valuation, potentially leading to increased investor interest and a positive short-term price movement.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 90